Breaking News Instant updates and real-time market news.

ORCL

Oracle

$49.64

-0.32 (-0.64%)

09:07
08/08/17
08/08
09:07
08/08/17
09:07

Oracle releases Banking Payments solution worldwide

Oracle announced the worldwide release of its Oracle Banking Payments solution. The offering was built from the ground up leveraging ISO 20022 and is designed to help banks compartmentalize payments messaging, message transformation and payment processing while providing high fidelity insight. Using the Oracle Banking Payments API, banks can also innovate within the Internet of Payments, collaboration with 3rd parties or curate new business models in collaboration with Fintechs.

ORCL Oracle
$49.64

-0.32 (-0.64%)

06/26/17
MUFG
06/26/17
NO CHANGE
Target $63
MUFG
Overweight
Oracle price target raised to $63 from $50 at MUFG
MUFG analyst Stephen Bersey raised his price target for Oracle to $63 following last week's Q4 earnings report. The company's transition to the cloud has "significant momentum at this stage and has clearly passed its inflection point," Bersey tells investors in a research note. He expects Oracle will continue to grow its revenues and expand its non-GAAP operating margin. The analyst keeps an Overweight rating on the shares.
07/05/17
KEYB
07/05/17
UPGRADE
Target $61
KEYB
Overweight
Oracle upgraded to Overweight from Sector Weight at KeyBanc
KeyBanc analyst Monika Garg upgraded Oracle to Overweight with a $61 price target. The software provider closed Monday down 78c to $49.36. Oracle cloud could double to a $12B run-rate within two years, Garg tells investors in a research note. The analyst notes that feedback from partners increases her confidence in Oracle's ability to accelerate the conversion of more than 400,000 existing customers to its new cloud offerings. She sees "considerable upside" in the shares despite the 28% year-to-date rally.
07/05/17
07/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Oracle (ORCL) upgraded to Overweight from Sector Weight at KeyBanc with analyst Monika Garg saying Oracle cloud could double to a $12B run-rate within two years. 2. Chemours (CC) upgraded to Buy from Neutral at Citi with analyst P.J. Juvekar saying the recent stock selloff has created a good entry point. The analyst raised his price target for the shares to $45 from $43. 3. BHP Billiton (BHP) upgraded to Outperform from Market Perform at Bernstein with analyst Paul Gait citing valuation and his belief that the company has "world-class mining portfolio and commodity mix." 4. PPG (PPG) upgraded to Buy from Hold at Argus with analyst Bill Selesky saying he believes that the company "will benefit from improving economic conditions in Europe." 5. Oneok (OKE) upgraded on lower risk, overblown concerns at BMO Capital with analyst Danilo Juvane saying the large increase in the percentage of the company's EBITDA coming from fee-based and take-or-pay assets in the past few years has significantly lowered the company's risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/12/17
KEYB
07/12/17
NO CHANGE
KEYB
Cloud business can propel Oracle stock to $78 in five years, says KeyBanc
KeyBanc says that Oracle's stock can reach $78 in five years. The firm believes that the company's cloud revenue can jump to $20B from $3.7B, while its free cash flow per share can reach $4.60 in 2021 versus $2.92 last year.

TODAY'S FREE FLY STORIES

15:00
09/24/18
09/24
15:00
09/24/18
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

KOS

Kosmos

$9.45

-0.06 (-0.63%)

14:58
09/24/18
09/24
14:58
09/24/18
14:58
Hot Stocks
Breaking Hot Stocks news story on Kosmos »

First Reserve GP XIII…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$10.76

-0.3 (-2.71%)

14:58
09/24/18
09/24
14:58
09/24/18
14:58
Conference/Events
Switch management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

CGC

Canopy Growth

$52.68

2.92 (5.87%)

, CVSI

CV Sciences

$0.00

(0.00%)

14:55
09/24/18
09/24
14:55
09/24/18
14:55
Hot Stocks
NY Governor signs bill adding pain management as condition for medical marijuana »

New York Governor Andrew…

CGC

Canopy Growth

$52.68

2.92 (5.87%)

CVSI

CV Sciences

$0.00

(0.00%)

ACBFF

Aurora Cannabis

$0.00

(0.00%)

CRON

Cronos Group

$11.80

-0.71 (-5.68%)

TLRY

Tilray

$105.00

-18.155 (-14.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

SBUX

Starbucks

$56.88

-0.52 (-0.91%)

14:50
09/24/18
09/24
14:50
09/24/18
14:50
Periodicals
Starbucks plans 'significant changes' to company structure, Bloomberg says »

Starbucks'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

RRGB

Red Robin

$38.65

-0.55 (-1.40%)

14:50
09/24/18
09/24
14:50
09/24/18
14:50
Conference/Events
Red Robin management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ASNA

Ascena Retail

$3.94

-0.29 (-6.86%)

14:49
09/24/18
09/24
14:49
09/24/18
14:49
Options
Ascena Retail options imply 24.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

AMRN

Amarin

$11.13

8.13 (271.00%)

, SNY

Sanofi

$43.33

-0.28 (-0.64%)

14:48
09/24/18
09/24
14:48
09/24/18
14:48
Hot Stocks
Amarin CEO says Vascepa 'more analogous' to statins than PCSK9 inhibitors »

Amarin CEO John Thero…

AMRN

Amarin

$11.13

8.13 (271.00%)

SNY

Sanofi

$43.33

-0.28 (-0.64%)

REGN

Regeneron

$388.88

-1.67 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 20

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

TRXC

TransEnterix

$6.70

0.27 (4.20%)

14:45
09/24/18
09/24
14:45
09/24/18
14:45
Options
TransEnterix call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 27

    Nov

SPPI

Spectrum

$17.18

-4.19 (-19.61%)

14:44
09/24/18
09/24
14:44
09/24/18
14:44
Hot Stocks
Spectrum drops over 20% after releasing poziotinib data from Phase 2 study »

Shares of Spectrum are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

JNJ

Johnson & Johnson

$140.67

-2.18 (-1.53%)

14:43
09/24/18
09/24
14:43
09/24/18
14:43
Periodicals
J&J talc cancer case in California ends in mistrial, Bloomberg reports »

Johnson &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

VSTM

Verastem

$8.98

0.31 (3.58%)

14:39
09/24/18
09/24
14:39
09/24/18
14:39
Hot Stocks
Verastem's Duvelisib approved by FDA »

Duvelisib capsules for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

VSTM

Verastem

$8.98

0.31 (3.58%)

14:38
09/24/18
09/24
14:38
09/24/18
14:38
Hot Stocks
Breaking Hot Stocks news story on Verastem »

Verastem trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

P

Pandora

$9.07

-0.01 (-0.11%)

14:30
09/24/18
09/24
14:30
09/24/18
14:30
Options
Heavy trading in Pandora Monday »

Heavy trading in Pandora…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

GOOG

Alphabet

$1,176.08

9.87 (0.85%)

, GOOGL

Alphabet Class A

$1,183.18

10.96 (0.93%)

14:28
09/24/18
09/24
14:28
09/24/18
14:28
Periodicals
Google to bring Google Lens to Image search results, Engadget says »

According to Engadget,…

GOOG

Alphabet

$1,176.08

9.87 (0.85%)

GOOGL

Alphabet Class A

$1,183.18

10.96 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

VIAB

Viacom

$32.44

0.08 (0.25%)

14:25
09/24/18
09/24
14:25
09/24/18
14:25
Options
Viacom call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
09/24/18
09/24
14:25
09/24/18
14:25
General news
FOMC begins its 2-day meeting Tuesday, with the announcement due Wednesday at 14 ET »

FOMC begins its 2-day…

ESRX

Express Scripts

$94.41

-0.2 (-0.21%)

, GILD

Gilead

$75.68

0.17 (0.23%)

14:20
09/24/18
09/24
14:20
09/24/18
14:20
Hot Stocks
Express Scripts calls Gilead action 'step in the right direction' »

Express Scripts (ESRX)…

ESRX

Express Scripts

$94.41

-0.2 (-0.21%)

GILD

Gilead

$75.68

0.17 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/24/18
09/24
14:17
09/24/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/24/18
09/24
14:16
09/24/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,177.62

11.41 (0.98%)

, GOOGL

Alphabet Class A

$1,184.38

12.16 (1.04%)

14:13
09/24/18
09/24
14:13
09/24/18
14:13
Hot Stocks
Google launches 'major update' Discover for Search »

Google said in a blog…

GOOG

Alphabet

$1,177.62

11.41 (0.98%)

GOOGL

Alphabet Class A

$1,184.38

12.16 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

14:10
09/24/18
09/24
14:10
09/24/18
14:10
General news
U.S. equities stabilized above lows after the Rosengren rout »

U.S. equities stabilized…

KORS

Michael Kors

$67.16

-5.51 (-7.58%)

14:09
09/24/18
09/24
14:09
09/24/18
14:09
Recommendations
Michael Kors analyst commentary  »

Versace not seen by many…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$140.70

-2.15 (-1.51%)

, BSX

Boston Scientific

$38.33

0.57 (1.51%)

14:05
09/24/18
09/24
14:05
09/24/18
14:05
Periodicals
J&J may be interested in Boston Scientific, Edwards Lifesciences, Barron's says »

According to an earlier…

JNJ

Johnson & Johnson

$140.70

-2.15 (-1.51%)

BSX

Boston Scientific

$38.33

0.57 (1.51%)

EW

Edwards Lifesciences

$165.13

11.42 (7.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 09

    Oct

  • 16

    Oct

  • 28

    Oct

VKTX

Viking Therapeutics

$18.77

0.555 (3.05%)

14:05
09/24/18
09/24
14:05
09/24/18
14:05
Options
Viking Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.